nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—F10—uterine cervix—ovarian cancer	0.0136	0.166	CbGeAlD
Fondaparinux sodium—F10—decidua—ovarian cancer	0.013	0.159	CbGeAlD
Fondaparinux sodium—F10—endometrium—ovarian cancer	0.0123	0.151	CbGeAlD
Fondaparinux sodium—F10—female reproductive system—ovarian cancer	0.0102	0.125	CbGeAlD
Fondaparinux sodium—F10—female gonad—ovarian cancer	0.00929	0.113	CbGeAlD
Fondaparinux sodium—F10—vagina—ovarian cancer	0.00924	0.113	CbGeAlD
Fondaparinux sodium—F10—testis—ovarian cancer	0.00824	0.101	CbGeAlD
Fondaparinux sodium—F10—lymph node—ovarian cancer	0.00597	0.0729	CbGeAlD
Fondaparinux sodium—Convulsion—Paclitaxel—ovarian cancer	0.000812	0.000884	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Epirubicin—ovarian cancer	0.000809	0.000881	CcSEcCtD
Fondaparinux sodium—Pruritus—Vinorelbine—ovarian cancer	0.000804	0.000876	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000801	0.000872	CcSEcCtD
Fondaparinux sodium—Chest pain—Paclitaxel—ovarian cancer	0.000797	0.000869	CcSEcCtD
Fondaparinux sodium—Anxiety—Paclitaxel—ovarian cancer	0.000795	0.000866	CcSEcCtD
Fondaparinux sodium—Malnutrition—Docetaxel—ovarian cancer	0.000794	0.000865	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000792	0.000863	CcSEcCtD
Fondaparinux sodium—Nausea—Topotecan—ovarian cancer	0.000789	0.00086	CcSEcCtD
Fondaparinux sodium—Gastritis—Epirubicin—ovarian cancer	0.000787	0.000857	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000784	0.000854	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Doxorubicin—ovarian cancer	0.000782	0.000852	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vinorelbine—ovarian cancer	0.000778	0.000847	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Docetaxel—ovarian cancer	0.000777	0.000847	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Epirubicin—ovarian cancer	0.000774	0.000843	CcSEcCtD
Fondaparinux sodium—Nausea—Melphalan—ovarian cancer	0.000773	0.000842	CcSEcCtD
Fondaparinux sodium—Confusional state—Paclitaxel—ovarian cancer	0.000771	0.00084	CcSEcCtD
Fondaparinux sodium—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000771	0.00084	CcSEcCtD
Fondaparinux sodium—Dysphagia—Epirubicin—ovarian cancer	0.000769	0.000837	CcSEcCtD
Fondaparinux sodium—Back pain—Docetaxel—ovarian cancer	0.000768	0.000836	CcSEcCtD
Fondaparinux sodium—Dehydration—Doxorubicin—ovarian cancer	0.000765	0.000833	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000764	0.000833	CcSEcCtD
Fondaparinux sodium—Oedema—Paclitaxel—ovarian cancer	0.000764	0.000833	CcSEcCtD
Fondaparinux sodium—Infection—Paclitaxel—ovarian cancer	0.000759	0.000827	CcSEcCtD
Fondaparinux sodium—Shock—Paclitaxel—ovarian cancer	0.000752	0.000819	CcSEcCtD
Fondaparinux sodium—Dizziness—Vinorelbine—ovarian cancer	0.000752	0.000819	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Paclitaxel—ovarian cancer	0.00075	0.000817	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Doxorubicin—ovarian cancer	0.000749	0.000816	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000748	0.000815	CcSEcCtD
Fondaparinux sodium—Tachycardia—Paclitaxel—ovarian cancer	0.000746	0.000813	CcSEcCtD
Fondaparinux sodium—Skin disorder—Paclitaxel—ovarian cancer	0.000743	0.000809	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000741	0.000807	CcSEcCtD
Fondaparinux sodium—Bronchitis—Epirubicin—ovarian cancer	0.000739	0.000805	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000739	0.000805	CcSEcCtD
Fondaparinux sodium—Anaemia—Docetaxel—ovarian cancer	0.000734	0.000799	CcSEcCtD
Fondaparinux sodium—Anorexia—Paclitaxel—ovarian cancer	0.000729	0.000794	CcSEcCtD
Fondaparinux sodium—Gastritis—Doxorubicin—ovarian cancer	0.000728	0.000793	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000726	0.00079	CcSEcCtD
Fondaparinux sodium—Vomiting—Vinorelbine—ovarian cancer	0.000723	0.000787	CcSEcCtD
Fondaparinux sodium—Rash—Vinorelbine—ovarian cancer	0.000717	0.000781	CcSEcCtD
Fondaparinux sodium—Dermatitis—Vinorelbine—ovarian cancer	0.000716	0.00078	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Doxorubicin—ovarian cancer	0.000716	0.00078	CcSEcCtD
Fondaparinux sodium—Hypotension—Paclitaxel—ovarian cancer	0.000714	0.000778	CcSEcCtD
Fondaparinux sodium—Headache—Vinorelbine—ovarian cancer	0.000712	0.000776	CcSEcCtD
Fondaparinux sodium—Syncope—Docetaxel—ovarian cancer	0.000712	0.000775	CcSEcCtD
Fondaparinux sodium—Dysphagia—Doxorubicin—ovarian cancer	0.000711	0.000775	CcSEcCtD
Fondaparinux sodium—Palpitations—Docetaxel—ovarian cancer	0.000702	0.000764	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Docetaxel—ovarian cancer	0.000698	0.00076	CcSEcCtD
Fondaparinux sodium—Cough—Docetaxel—ovarian cancer	0.000693	0.000755	CcSEcCtD
Fondaparinux sodium—Insomnia—Paclitaxel—ovarian cancer	0.000691	0.000753	CcSEcCtD
Fondaparinux sodium—Convulsion—Docetaxel—ovarian cancer	0.000688	0.000749	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Paclitaxel—ovarian cancer	0.000686	0.000748	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Epirubicin—ovarian cancer	0.000685	0.000746	CcSEcCtD
Fondaparinux sodium—Infestation—Epirubicin—ovarian cancer	0.000685	0.000746	CcSEcCtD
Fondaparinux sodium—Bronchitis—Doxorubicin—ovarian cancer	0.000684	0.000745	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Paclitaxel—ovarian cancer	0.000682	0.000742	CcSEcCtD
Fondaparinux sodium—Somnolence—Paclitaxel—ovarian cancer	0.00068	0.00074	CcSEcCtD
Fondaparinux sodium—Chest pain—Docetaxel—ovarian cancer	0.000676	0.000736	CcSEcCtD
Fondaparinux sodium—Nausea—Vinorelbine—ovarian cancer	0.000675	0.000735	CcSEcCtD
Fondaparinux sodium—Renal failure—Epirubicin—ovarian cancer	0.000674	0.000734	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Paclitaxel—ovarian cancer	0.000673	0.000733	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000671	0.000731	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Epirubicin—ovarian cancer	0.000666	0.000725	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Paclitaxel—ovarian cancer	0.000665	0.000724	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00066	0.000719	CcSEcCtD
Fondaparinux sodium—Fatigue—Paclitaxel—ovarian cancer	0.000659	0.000718	CcSEcCtD
Fondaparinux sodium—Pain—Paclitaxel—ovarian cancer	0.000654	0.000712	CcSEcCtD
Fondaparinux sodium—Constipation—Paclitaxel—ovarian cancer	0.000654	0.000712	CcSEcCtD
Fondaparinux sodium—Haematuria—Epirubicin—ovarian cancer	0.000653	0.000712	CcSEcCtD
Fondaparinux sodium—Confusional state—Docetaxel—ovarian cancer	0.000653	0.000712	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000648	0.000706	CcSEcCtD
Fondaparinux sodium—Oedema—Docetaxel—ovarian cancer	0.000648	0.000706	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Docetaxel—ovarian cancer	0.000648	0.000706	CcSEcCtD
Fondaparinux sodium—Epistaxis—Epirubicin—ovarian cancer	0.000646	0.000704	CcSEcCtD
Fondaparinux sodium—Infection—Docetaxel—ovarian cancer	0.000644	0.000701	CcSEcCtD
Fondaparinux sodium—Shock—Docetaxel—ovarian cancer	0.000637	0.000694	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Docetaxel—ovarian cancer	0.000635	0.000692	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Docetaxel—ovarian cancer	0.000634	0.000691	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Doxorubicin—ovarian cancer	0.000634	0.000691	CcSEcCtD
Fondaparinux sodium—Infestation—Doxorubicin—ovarian cancer	0.000634	0.000691	CcSEcCtD
Fondaparinux sodium—Tachycardia—Docetaxel—ovarian cancer	0.000632	0.000689	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Paclitaxel—ovarian cancer	0.00063	0.000686	CcSEcCtD
Fondaparinux sodium—Skin disorder—Docetaxel—ovarian cancer	0.000629	0.000686	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000625	0.000681	CcSEcCtD
Fondaparinux sodium—Renal failure—Doxorubicin—ovarian cancer	0.000623	0.000679	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Epirubicin—ovarian cancer	0.000618	0.000673	CcSEcCtD
Fondaparinux sodium—Anorexia—Docetaxel—ovarian cancer	0.000618	0.000673	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Doxorubicin—ovarian cancer	0.000616	0.000671	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Epirubicin—ovarian cancer	0.000615	0.00067	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Epirubicin—ovarian cancer	0.000612	0.000667	CcSEcCtD
Fondaparinux sodium—Urticaria—Paclitaxel—ovarian cancer	0.000607	0.000661	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Epirubicin—ovarian cancer	0.000606	0.00066	CcSEcCtD
Fondaparinux sodium—Hypotension—Docetaxel—ovarian cancer	0.000605	0.000659	CcSEcCtD
Fondaparinux sodium—Haematuria—Doxorubicin—ovarian cancer	0.000605	0.000658	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Paclitaxel—ovarian cancer	0.000604	0.000658	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Paclitaxel—ovarian cancer	0.000604	0.000658	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.0006	0.000653	CcSEcCtD
Fondaparinux sodium—Epistaxis—Doxorubicin—ovarian cancer	0.000598	0.000651	CcSEcCtD
Fondaparinux sodium—Insomnia—Docetaxel—ovarian cancer	0.000586	0.000638	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Docetaxel—ovarian cancer	0.000582	0.000634	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Docetaxel—ovarian cancer	0.000578	0.000629	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—ovarian cancer	0.000576	0.000627	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Doxorubicin—ovarian cancer	0.000572	0.000623	CcSEcCtD
Fondaparinux sodium—Flushing—Epirubicin—ovarian cancer	0.000571	0.000622	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Docetaxel—ovarian cancer	0.00057	0.000621	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Doxorubicin—ovarian cancer	0.000569	0.00062	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000566	0.000617	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Docetaxel—ovarian cancer	0.000563	0.000614	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Paclitaxel—ovarian cancer	0.000563	0.000613	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Doxorubicin—ovarian cancer	0.000561	0.000611	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000559	0.000609	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—ovarian cancer	0.000559	0.000608	CcSEcCtD
Fondaparinux sodium—Angiopathy—Epirubicin—ovarian cancer	0.000558	0.000608	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Epirubicin—ovarian cancer	0.000556	0.000605	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Epirubicin—ovarian cancer	0.000554	0.000604	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—ovarian cancer	0.000554	0.000604	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—ovarian cancer	0.000554	0.000604	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Epirubicin—ovarian cancer	0.00055	0.000599	CcSEcCtD
Fondaparinux sodium—Asthenia—Paclitaxel—ovarian cancer	0.000548	0.000597	CcSEcCtD
Fondaparinux sodium—Pruritus—Paclitaxel—ovarian cancer	0.000541	0.000589	CcSEcCtD
Fondaparinux sodium—Malnutrition—Epirubicin—ovarian cancer	0.000535	0.000583	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Docetaxel—ovarian cancer	0.000534	0.000582	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00053	0.000577	CcSEcCtD
Fondaparinux sodium—Flushing—Doxorubicin—ovarian cancer	0.000528	0.000575	CcSEcCtD
Fondaparinux sodium—Flatulence—Epirubicin—ovarian cancer	0.000528	0.000575	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Epirubicin—ovarian cancer	0.000524	0.000571	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Paclitaxel—ovarian cancer	0.000523	0.00057	CcSEcCtD
Fondaparinux sodium—Back pain—Epirubicin—ovarian cancer	0.000518	0.000564	CcSEcCtD
Fondaparinux sodium—Angiopathy—Doxorubicin—ovarian cancer	0.000516	0.000562	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Doxorubicin—ovarian cancer	0.000514	0.00056	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000513	0.000559	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Docetaxel—ovarian cancer	0.000512	0.000558	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—ovarian cancer	0.000512	0.000558	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Doxorubicin—ovarian cancer	0.000508	0.000554	CcSEcCtD
Fondaparinux sodium—Dizziness—Paclitaxel—ovarian cancer	0.000506	0.000551	CcSEcCtD
Fondaparinux sodium—Vision blurred—Epirubicin—ovarian cancer	0.000505	0.00055	CcSEcCtD
Fondaparinux sodium—Malnutrition—Doxorubicin—ovarian cancer	0.000495	0.00054	CcSEcCtD
Fondaparinux sodium—Anaemia—Epirubicin—ovarian cancer	0.000495	0.000539	CcSEcCtD
Fondaparinux sodium—Flatulence—Doxorubicin—ovarian cancer	0.000488	0.000532	CcSEcCtD
Fondaparinux sodium—Vomiting—Paclitaxel—ovarian cancer	0.000486	0.000529	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Doxorubicin—ovarian cancer	0.000485	0.000528	CcSEcCtD
Fondaparinux sodium—Rash—Paclitaxel—ovarian cancer	0.000482	0.000525	CcSEcCtD
Fondaparinux sodium—Dermatitis—Paclitaxel—ovarian cancer	0.000482	0.000525	CcSEcCtD
Fondaparinux sodium—Vertigo—Epirubicin—ovarian cancer	0.000481	0.000524	CcSEcCtD
Fondaparinux sodium—Syncope—Epirubicin—ovarian cancer	0.00048	0.000523	CcSEcCtD
Fondaparinux sodium—Back pain—Doxorubicin—ovarian cancer	0.000479	0.000522	CcSEcCtD
Fondaparinux sodium—Headache—Paclitaxel—ovarian cancer	0.000479	0.000522	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Docetaxel—ovarian cancer	0.000477	0.00052	CcSEcCtD
Fondaparinux sodium—Palpitations—Epirubicin—ovarian cancer	0.000473	0.000515	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Epirubicin—ovarian cancer	0.000471	0.000513	CcSEcCtD
Fondaparinux sodium—Cough—Epirubicin—ovarian cancer	0.000467	0.000509	CcSEcCtD
Fondaparinux sodium—Vision blurred—Doxorubicin—ovarian cancer	0.000467	0.000509	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—ovarian cancer	0.000465	0.000506	CcSEcCtD
Fondaparinux sodium—Convulsion—Epirubicin—ovarian cancer	0.000464	0.000505	CcSEcCtD
Fondaparinux sodium—Pruritus—Docetaxel—ovarian cancer	0.000458	0.000499	CcSEcCtD
Fondaparinux sodium—Anaemia—Doxorubicin—ovarian cancer	0.000458	0.000499	CcSEcCtD
Fondaparinux sodium—Chest pain—Epirubicin—ovarian cancer	0.000456	0.000497	CcSEcCtD
Fondaparinux sodium—Anxiety—Epirubicin—ovarian cancer	0.000454	0.000495	CcSEcCtD
Fondaparinux sodium—Nausea—Paclitaxel—ovarian cancer	0.000454	0.000495	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000453	0.000493	CcSEcCtD
Fondaparinux sodium—Vertigo—Doxorubicin—ovarian cancer	0.000445	0.000485	CcSEcCtD
Fondaparinux sodium—Syncope—Doxorubicin—ovarian cancer	0.000444	0.000484	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Docetaxel—ovarian cancer	0.000443	0.000483	CcSEcCtD
Fondaparinux sodium—Confusional state—Epirubicin—ovarian cancer	0.000441	0.00048	CcSEcCtD
Fondaparinux sodium—Palpitations—Doxorubicin—ovarian cancer	0.000438	0.000477	CcSEcCtD
Fondaparinux sodium—Oedema—Epirubicin—ovarian cancer	0.000437	0.000476	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Epirubicin—ovarian cancer	0.000437	0.000476	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Doxorubicin—ovarian cancer	0.000435	0.000474	CcSEcCtD
Fondaparinux sodium—Infection—Epirubicin—ovarian cancer	0.000434	0.000473	CcSEcCtD
Fondaparinux sodium—Cough—Doxorubicin—ovarian cancer	0.000432	0.000471	CcSEcCtD
Fondaparinux sodium—Shock—Epirubicin—ovarian cancer	0.00043	0.000468	CcSEcCtD
Fondaparinux sodium—Convulsion—Doxorubicin—ovarian cancer	0.000429	0.000468	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Epirubicin—ovarian cancer	0.000429	0.000467	CcSEcCtD
Fondaparinux sodium—Dizziness—Docetaxel—ovarian cancer	0.000428	0.000467	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Epirubicin—ovarian cancer	0.000428	0.000466	CcSEcCtD
Fondaparinux sodium—Tachycardia—Epirubicin—ovarian cancer	0.000427	0.000465	CcSEcCtD
Fondaparinux sodium—Skin disorder—Epirubicin—ovarian cancer	0.000425	0.000462	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Epirubicin—ovarian cancer	0.000422	0.00046	CcSEcCtD
Fondaparinux sodium—Chest pain—Doxorubicin—ovarian cancer	0.000422	0.000459	CcSEcCtD
Fondaparinux sodium—Anxiety—Doxorubicin—ovarian cancer	0.00042	0.000458	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000419	0.000456	CcSEcCtD
Fondaparinux sodium—Anorexia—Epirubicin—ovarian cancer	0.000417	0.000454	CcSEcCtD
Fondaparinux sodium—Vomiting—Docetaxel—ovarian cancer	0.000412	0.000449	CcSEcCtD
Fondaparinux sodium—Rash—Docetaxel—ovarian cancer	0.000409	0.000445	CcSEcCtD
Fondaparinux sodium—Hypotension—Epirubicin—ovarian cancer	0.000408	0.000445	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—ovarian cancer	0.000408	0.000445	CcSEcCtD
Fondaparinux sodium—Confusional state—Doxorubicin—ovarian cancer	0.000408	0.000444	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—ovarian cancer	0.000406	0.000442	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000404	0.00044	CcSEcCtD
Fondaparinux sodium—Oedema—Doxorubicin—ovarian cancer	0.000404	0.00044	CcSEcCtD
Fondaparinux sodium—Infection—Doxorubicin—ovarian cancer	0.000402	0.000438	CcSEcCtD
Fondaparinux sodium—Shock—Doxorubicin—ovarian cancer	0.000398	0.000433	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Doxorubicin—ovarian cancer	0.000397	0.000432	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000396	0.000431	CcSEcCtD
Fondaparinux sodium—Insomnia—Epirubicin—ovarian cancer	0.000395	0.000431	CcSEcCtD
Fondaparinux sodium—Tachycardia—Doxorubicin—ovarian cancer	0.000395	0.00043	CcSEcCtD
Fondaparinux sodium—Skin disorder—Doxorubicin—ovarian cancer	0.000393	0.000428	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Epirubicin—ovarian cancer	0.000392	0.000427	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000391	0.000426	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Epirubicin—ovarian cancer	0.00039	0.000424	CcSEcCtD
Fondaparinux sodium—Somnolence—Epirubicin—ovarian cancer	0.000389	0.000423	CcSEcCtD
Fondaparinux sodium—Anorexia—Doxorubicin—ovarian cancer	0.000385	0.00042	CcSEcCtD
Fondaparinux sodium—Nausea—Docetaxel—ovarian cancer	0.000385	0.000419	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Epirubicin—ovarian cancer	0.000385	0.000419	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Epirubicin—ovarian cancer	0.00038	0.000414	CcSEcCtD
Fondaparinux sodium—Hypotension—Doxorubicin—ovarian cancer	0.000378	0.000412	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000377	0.000411	CcSEcCtD
Fondaparinux sodium—Fatigue—Epirubicin—ovarian cancer	0.000377	0.00041	CcSEcCtD
Fondaparinux sodium—Pain—Epirubicin—ovarian cancer	0.000374	0.000407	CcSEcCtD
Fondaparinux sodium—Constipation—Epirubicin—ovarian cancer	0.000374	0.000407	CcSEcCtD
Fondaparinux sodium—Insomnia—Doxorubicin—ovarian cancer	0.000366	0.000398	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Doxorubicin—ovarian cancer	0.000363	0.000396	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Doxorubicin—ovarian cancer	0.000361	0.000393	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Epirubicin—ovarian cancer	0.00036	0.000392	CcSEcCtD
Fondaparinux sodium—Somnolence—Doxorubicin—ovarian cancer	0.000359	0.000392	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000357	0.000389	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Doxorubicin—ovarian cancer	0.000356	0.000388	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Doxorubicin—ovarian cancer	0.000352	0.000383	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000349	0.00038	CcSEcCtD
Fondaparinux sodium—Fatigue—Doxorubicin—ovarian cancer	0.000349	0.00038	CcSEcCtD
Fondaparinux sodium—Urticaria—Epirubicin—ovarian cancer	0.000347	0.000378	CcSEcCtD
Fondaparinux sodium—Pain—Doxorubicin—ovarian cancer	0.000346	0.000377	CcSEcCtD
Fondaparinux sodium—Constipation—Doxorubicin—ovarian cancer	0.000346	0.000377	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Epirubicin—ovarian cancer	0.000345	0.000376	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Epirubicin—ovarian cancer	0.000345	0.000376	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Doxorubicin—ovarian cancer	0.000333	0.000363	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000331	0.00036	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Epirubicin—ovarian cancer	0.000322	0.000351	CcSEcCtD
Fondaparinux sodium—Urticaria—Doxorubicin—ovarian cancer	0.000321	0.00035	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Doxorubicin—ovarian cancer	0.00032	0.000348	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Doxorubicin—ovarian cancer	0.00032	0.000348	CcSEcCtD
Fondaparinux sodium—Asthenia—Epirubicin—ovarian cancer	0.000314	0.000342	CcSEcCtD
Fondaparinux sodium—Pruritus—Epirubicin—ovarian cancer	0.000309	0.000337	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Epirubicin—ovarian cancer	0.000299	0.000326	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Doxorubicin—ovarian cancer	0.000298	0.000325	CcSEcCtD
Fondaparinux sodium—Asthenia—Doxorubicin—ovarian cancer	0.00029	0.000316	CcSEcCtD
Fondaparinux sodium—Dizziness—Epirubicin—ovarian cancer	0.000289	0.000315	CcSEcCtD
Fondaparinux sodium—Pruritus—Doxorubicin—ovarian cancer	0.000286	0.000312	CcSEcCtD
Fondaparinux sodium—Vomiting—Epirubicin—ovarian cancer	0.000278	0.000303	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Doxorubicin—ovarian cancer	0.000277	0.000301	CcSEcCtD
Fondaparinux sodium—Rash—Epirubicin—ovarian cancer	0.000276	0.0003	CcSEcCtD
Fondaparinux sodium—Dermatitis—Epirubicin—ovarian cancer	0.000275	0.0003	CcSEcCtD
Fondaparinux sodium—Headache—Epirubicin—ovarian cancer	0.000274	0.000298	CcSEcCtD
Fondaparinux sodium—Dizziness—Doxorubicin—ovarian cancer	0.000267	0.000291	CcSEcCtD
Fondaparinux sodium—Nausea—Epirubicin—ovarian cancer	0.00026	0.000283	CcSEcCtD
Fondaparinux sodium—Vomiting—Doxorubicin—ovarian cancer	0.000257	0.00028	CcSEcCtD
Fondaparinux sodium—Rash—Doxorubicin—ovarian cancer	0.000255	0.000278	CcSEcCtD
Fondaparinux sodium—Dermatitis—Doxorubicin—ovarian cancer	0.000255	0.000277	CcSEcCtD
Fondaparinux sodium—Headache—Doxorubicin—ovarian cancer	0.000253	0.000276	CcSEcCtD
Fondaparinux sodium—Nausea—Doxorubicin—ovarian cancer	0.00024	0.000262	CcSEcCtD
